Authors: Smalley, RV Weller, E Hawkins, MJ Oken, MM O'Connell, MJ Haase-Statz, S Borden, EC

Citation: Rv. Smalley et al., Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-alpha 2a) plus an anthracycline-based induction regimen, LEUKEMIA, 15(7), 2001, pp. 1118-1122

Authors: Smalley, RV Guaspari, A Haase-Statz, S Anderson, SA Cederberg, D Hohneker, JA

Citation: Rv. Smalley et al., Allopurinol: Intravenous use for prevention and treatment of hyperuricemia, J CL ONCOL, 18(8), 2000, pp. 1758-1763

Authors: Haase-Statz, S Smalley, RV

Citation: S. Haase-statz et Rv. Smalley, Role of interferon-alfa in NHL: Still controversial?, ONCOLOGY-NY, 13(8), 1999, pp. 1147